SMAD4 and cancer: Agonist Zfra4-10 or WWOX7-21 peptide, HYAL-2 antibody or sonicated hyaluronan HAson8, also activate the HYAL-2/WWOX/SMAD4 signaling for spleen Z cell activation in order to kill cancer cells in vitro and in vivo.